Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers

Keyphrases

• Plasma Parameters 100%
• Multiple Sclerosis Treatment 100%
• Osteopontin 100%
• Specific Marker 100%
• Immunoglobulin G Index 31%
• MRNA Level 18%
• Relapsing-remitting multiple Sclerosis 18%
• Peripheral Blood Mononuclear Cells 18%
• Cerebrospinal Fluid 12%
• Healthy Controls 6%
• Inflammatory Cytokines 6%
• Quantitative PCR 6%
• Paired Samples 6%
• Vitamin D 6%
• Serum Samples 6%
• Bone Metabolism 6%
• Cerebrospinal Fluid Samples 6%
• Fluid Level 6%
• Type I Collagen 6%
• Plasma Fluid 6%
• Multiple Sclerosis Lesions 6%
• Immunomodulatory Activity 6%
• Degradation Products 6%
• Polymerase Chain Reaction Analysis 6%
• Lesion Level 6%
• C-telopeptide 6%
• Specific Degradation 6%
• 25(OH) Vitamin D 6%
• Immunomodulatory Molecules 6%

INIS

• levels 100%
• patients 100%
• bones 100%
• plasma 100%
• immunoglobulins 41%
• blood 25%
• cerebrospinal fluid 25%
• messenger-rna 25%
• comparative evaluations 16%
• molecules 16%
• vitamin d 16%
• collagen 8%
• control 8%
• metabolism 8%
• polymerase chain reaction 8%
• inflammation 8%
• cytokines 8%

Neuroscience

• Multiple Sclerosis 100%
• Osteopontin 100%
• Blood Plasma 100%
• Immunoglobulin G 31%
• Peripheral Blood Mononuclear Cell 18%
• Relapsing Remitting Multiple Sclerosis 18%
• Messenger RNA 18%
• Vitamin D 12%
• Metabolic Pathway 6%
• Proinflammatory Cytokine 6%
• Real-Time Polymerase Chain Reaction 6%
• Collagen Type 1 6%
• Telopeptide 6%